Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 12,266 | 13,187 | 12,309 | 12,153 | 11,718 |
| Cost of Goods | 1,155 | 1,300 | 1,108 | 1,310 | 1,096 |
| Gross Profit | 11,111 | 11,887 | 11,201 | 10,843 | 10,622 |
| Operating Expenses | 31,182 | 30,020 | 29,358 | 30,682 | 30,949 |
| Operating Income | -19,916 | -17,833 | -18,049 | -19,529 | -20,231 |
| Interest Expense | 1,696 | 1,683 | 1,679 | 1,658 | 1,655 |
| Other Income | 2,846 | 6,974 | 15,878 | 23,844 | 13,405 |
| Pre-tax Income | -18,766 | -12,542 | -3,850 | 2,657 | -8,481 |
| Net Income Continuous | -18,766 | -12,542 | -3,850 | 2,657 | -8,481 |
| Net Income | $-18,766 | $-12,542 | $-3,850 | $2,657 | $-8,481 |
| EPS Basic Total Ops | -0.24 | -0.16 | -0.05 | 0.03 | -0.11 |
| EPS Basic Continuous Ops | -0.24 | -0.16 | -0.05 | 0.03 | -0.11 |
| EPS Diluted Total Ops | -0.25 | -0.22 | -0.26 | -0.23 | -0.25 |
| EPS Diluted Continuous Ops | -0.23 | -0.15 | -0.04 | 0.03 | -0.10 |
| EBITDA(a) | $-19,364 | $-17,276 | $-17,479 | $-18,935 | $-19,620 |